Superior-Division Infarct of the Middle Cerebral Artery

The middle cerebral artery splits into superior and inferior divisions just after it leaves the Sylvian fissure. An occlusion limited to the superior branch starves the dorsolateral frontal lobe, pre-motor and primary motor cortex that drive the face, hand, and upper arm. Language zones (Broca’s area) also sit here on the dominant side. Because the medial leg strip is spared, leg power often remains near normal. Patients therefore present with contralateral lower-face droop, arm weakness > leg, non-fluent aphasia (if left-hemisphere) or visuospatial neglect (if right) and, when large enough, a gaze preference toward the lesion?. Early CT? or MRI? diffusion-weighted imaging pinpoints the cortical ribbon and rules out hemorrhage. Superior-division events make up roughly half of all cortical MCA strokes. my.clevelandclinic.orgncbi.nlm.nih.gov

Types of Superior-Division Infarct

Stroke neurologists informally subdivide this syndrome? to guide prognosis? and therapy:

1. Complete trunk occlusion – The whole superior M2 stem is blocked, producing dense faciobrachial paralysis? and, in the dominant hemisphere, a classic Broca aphasia with reading and writing impairment.

2. Partial (branch‐selective) infarct – Only one frontal or parietal cortical branch is obstructed; deficits are focal (e.g., isolated hand weakness or apraxia).

3. Border-zone (watershed) extension – Hypoperfusion spreads into the ACA–MCA watershed, adding leg weakness and, occasionally, abulia.

4. Dominant-hemisphere infarct – Broca aphasia, agrammatism, dysarthria, impaired repetition, with preserved comprehension; emotional frustration is common.

5. Non-dominant-hemisphere infarct – Severe? left-sided neglect, anosognosia, constructional apraxia, and sometimes forced-gaze deviation toward the right.

6. Combined cortical-subcortical pattern – When clot fragments shower lenticulostriate perforators, deep motor fibres in the posterior limb of the internal capsule die, amplifying weakness.

7. Early-reperfusion (“spectacular shrinking deficit”) – Rapid thrombolysis or spontaneous lysis rescues penumbral tissue, and dramatic recovery occurs within hours.

8. Malignant? frontal infarct – A large proximal clot causes massive oedema, raised intracranial pressure?, and early herniation; decompressive hemicraniectomy may be lifesaving.

9. Stepwise (lacuno-cortical) progression? – Successive emboli or in-situ thrombosis? enlarge the lesion over 24–48 h, producing a stuttering course.

10. Silent cortical infarct – Tiny branch occlusions may remain asymptomatic? or present only with subtle executive slowing, detectable on MRI during work-up for another reason.

Causes

1. Atherosclerotic plaque? rupture in the internal carotid artery – Cholesterol?-rich plaque cracks, a clot forms, and bits of thrombus break off and sail into the superior trunk.ncbi.nlm.nih.gov

2. Cardio-embolic atrial fibrillation? – An irregular heartbeat lets blood pool in the left atrium?, a clot forms and shoots up the carotid.

3. Patent foramen ovale with paradoxical embolus – A leg-vein? clot sneaks through the heart’s flap valve and lodges in the MCA.ncbi.nlm.nih.gov

4. Endocarditis? (infected heart valve?) – Septic debris or platelet?–fibrin clumps peel off the valve.

5. Prosthetic-valve thrombosis – Mechanical valves sometimes generate platelet-rich clots despite anticoagulation.

6. Carotid-artery dissection – A tear in the arterial wall traps blood; the false lumen spawns emboli.

7. Moyamoya or twig-like MCA anomaly – Fragile, narrowed collateral channels thrombose during hypotension?.

8. Hypercoagulable genetic? states (e.g., Factor V Leiden) – Blood clots too readily, encouraging in-situ thrombosis.

9. Antiphospholipid antibody syndrome – Auto-antibodies activate clotting cascades.

10. Sickle-cell disease? – Rigid red cells block arterioles and damage endothelium.

11. COVID-19-associated coagulopathy? – Viral? inflammation and platelet activation thicken the blood.

12. Hypertension-driven lipohyalinosis of small branches – Vessel walls scar, narrow, and ultimately occlude—especially in penetrating arterioles that feed the superior trunk.

13. Severe hyperlipidaemia – High LDL accelerates plaque growth in proximal MCA.

14. Smoking-induced endothelial dysfunction – Tobacco toxins injure the vessel lining and promote thrombosis.

15. Cocaine or amphetamine use – Sudden surges in blood pressure trigger vasospasm and clot.

16. Giant-cell (temporal) arteritis – Granulomatous inflammation narrows cerebral branches.

17. Radiation-induced vasculopathy after head-neck cancer therapy – Intimal fibrosis appears years later and occludes the trunk.

18. Post-partum cerebral angiopathy – Hormonal and haemodynamic shifts provoke reversible vasoconstriction and clot.

19. Malignancy-related non-bacterial thrombotic endocarditis – Mucin-rich tumours generate sterile vegetations that embolise.

20. Iatrogenic embolus during cardiac catheterisation – A dislodged aortic‐arch plaque travels upward.

Common Symptoms

1. Sudden weakness of the right (or left) face and arm – The opposite side of the body droops or feels heavy.ncbi.nlm.nih.govmy.clevelandclinic.orgen.wikipedia.org

2. Clumsy hand or fingers – Fine motor tasks like buttoning a shirt become impossible.

3. Slurred speech (dysarthria) – Mouth muscles are weak or poorly coordinated.my.clevelandclinic.org

4. Non-fluent or “telegraphic” speech (Broca aphasia) – Words come out laboriously, but understanding is intact.ncbi.nlm.nih.gov

5. Difficulty naming objects (anomia) – The word is “on the tip of the tongue.”

6. Grammatical errors (agrammatism) – Sentences lack small connecting words.

7. Reading and writing trouble (alexia/agraphia) – Letters appear jumbled or writing is effortful.

8. Forced gaze toward the stroke side – Eye-movement centres in frontal cortex misfire, so both eyes look rightward in a left hemiparesis.

9. Mild numbness of face or arm – Pins-and-needles, usually less severe than weakness.ncbi.nlm.nih.gov

10. Pronounced neglect of the opposite side – In non-dominant strokes, the person ignores the left body and space.

11. Apraxia (motor planning failure) – Can’t sequence movements to brush teeth despite having strength.

12. Difficulty with complex hand tasks (ideomotor apraxia) – Gesturing “wave goodbye” is clumsy.

13. Arm-drop drift – The raised arm drifts down involuntarily during testing.

14. Emotional frustration or depression – Insightful patients with Broca aphasia often cry easily.

15. Headache on stroke onset – Less common than in hemorrhage but may accompany large emboli.

16. Seizure (focal-to-generalised) – Irritated cortex fires abnormally, especially in younger patients.

17. Visual field “cut” (upper quadrantopia) – Superior division lesions rarely extend far enough posteriorly, but partial visual loss can occur when oedema spreads.

18. Impaired attention and working memory – Frontal cortex is offline, so the patient is distractible.

19. Primitive reflexes (grasp, pout) – Release signs emerge weeks later during recovery.

20. Muscle stiffness and spasticity – UMN signs appear as early flaccidity resolves.

Diagnostic Tests

A. Physical-Exam Assessments

1. NIH Stroke Scale (NIHSS) – A structured bedside score that quantifies stroke severity and predicts outcomes; items target language, motor power, gaze, neglect, and sensation.

2. Vital-sign survey – Blood pressure, pulse, oxygen saturation, temperature guide acute management.

3. Cranial-nerve examination – Detects facial droop, gaze palsy, dysarthria, and swallowing risk.

4. Motor strength grading – 0-to-5 scale identifies hemiparesis distribution and follow-up recovery.

5. Sensory testing (light-touch, pin, proprioception) – Delineates cortical from subcortical deficits.

6. Deep-tendon reflexes – Brisk reflexes and an upgoing plantar indicate upper-motor-neuron injury.

7. Coordination checks (finger-to-nose, rapid alternation) – Reveal cerebellar mimicry or true cortical dysfunction.

8. Gait observation – Identifies circumduction and foot-drop once ambulatory.

9. Assessment of neglect (line cancellation during exam) – Quick bedside screening in non-dominant strokes.

10. Swallow screen – Protects the airway by detecting dysphagia before oral intake.

B. Manual (Bedside-Provocation) Tests

11. Pronator-drift test – Supinated arm drifts downward/medially within 10 s, signalling corticospinal weakness.

12. Rapid finger-tapping – Slowed rate reflects fine-motor impairment in the MCA hand knob.

13. Limb-activation test – Examiner moves the weak arm; lack of spontaneous use suggests motor neglect.

14. Clock-drawing task – Visuospatial neglect and planning errors become obvious; quick cognitive screen.

15. Picture-description (Cookie-Theft) test – Elicits expressive language deficits or neglect in speech.

16. Apraxia screening (gesture imitation) – Patient copies symbolic gestures; difficulty = frontal-parietal damage.

17. Line-bisection task – Horizontal line is bisected too far to the right in left-neglect.

18. Frontal-release sign elicitation (grasp reflex) – Persistent grasping indicates extensive frontal injury.

C. Laboratory & Pathological Tests

19. Complete blood count (CBC) – Looks for anaemia and thrombocytopenia that influence thrombolysis safety.

20. Serum electrolytes and creatinine – Detect derangements that mimic stroke (e.g., hyponatraemia) and calculate contrast dose.

21. Random blood glucose – Hypoglycaemia or hyperglycaemia can present with focal deficits and worsens outcome.

22. Coagulation profile (PT/INR, aPTT) – Guides tPA eligibility and screens for coagulopathies.

23. Lipid profile – Identifies dyslipidaemia for secondary prevention.

24. HbA1c – Gauges chronic glycaemic control, a stroke risk modifier.

25. High-sensitivity CRP and ESR – Inflammatory markers hint at vasculitis or giant-cell arteritis.

26. Cardiac troponin – Detects concurrent myocardial injury from cardio-embolic sources.

27. D-dimer – Elevated in hypercoagulable or cancer-related strokes; prompts search for occult malignancy.

28. Thrombophilia panel (protein C, S, antithrombin, antiphospholipid antibodies) – Selectively ordered in young or cryptogenic cases.

D. Electro-Diagnostic Tests

29. 12-lead electrocardiogram (ECG) – Identifies atrial fibrillation, flutter, or acute MI as embolic sources.my.clevelandclinic.org

30. Continuous cardiac telemetry or Holter monitor – Catches paroxysmal arrhythmias missed on a single ECG.

31. Transcranial Doppler ultrasound (TCD) – Detects real-time micro-embolic signals and monitors recanalisation.

32. Carotid and vertebral duplex ultrasound (extra-cranial) – Measures stenosis that may require endarterectomy.

33. EEG (electroencephalography) – Rules out post-stroke seizures or non-convulsive status mimicking deficit.

34. Somatosensory evoked potentials (SSEP) – Estimates cortical sensory pathway integrity when patient is sedated.

35. Brainstem auditory evoked responses (BAER) – Adds prognostic data in comatose patients with suspected large-hemispheric infarcts.

36. Surface electromyography (EMG) during recovery – Quantifies spasticity and guides rehab strategies.

E. Imaging Investigations

37. Non-contrast CT head – Fast first-line test; rules out haemorrhage and may show early ischaemic change.my.clevelandclinic.org

38. CT angiography (CTA) of head and neck – Visualises the clot in the superior M2 trunk, collateral flow, carotid stenosis.

39. CT perfusion – Maps salvageable penumbra to support endovascular therapy up to 24 h.

40. MRI brain with diffusion-weighted imaging (DWI) – Highly sensitive for acute cortical infarction within minutes.

41. MR angiography (MRA) – Alternative to CTA when iodinated contrast is contraindicated.

42. Digital subtraction angiography (DSA) – Gold-standard vascular roadmap and portal for thrombectomy.

43. High-resolution vessel-wall MRI – Detects dissection flaps or vasculitis in the MCA trunk.

44. Gradient-echo (GRE) or susceptibility-weighted imaging (SWI) – Finds micro-haemorrhage that alters anticoagulation plans.

45. Positron-emission tomography (PET) cerebral blood-flow study – Research tool predicting infarct growth.

46. Repeat CT or MRI 24 h post-lysis – Confirms reperfusion and screens for haemorrhagic transformation.

Non-pharmacological treatments

Physiotherapy & electrotherapy

1. Constraint-Induced Movement Therapy (CIMT) – intensive, repetitive tasks with the affected limb while restraining the good limb; drives cortical re-mapping. Evidence: improves upper-limb function by ~25 % at 90 days. pubmed.ncbi.nlm.nih.gov

2. Task-Oriented Repetitive Practice – reach-grasp-release circuits, 300–400 reps/day to boost synaptic plasticity.

3. Mirror Therapy – reflecting healthy limb tricks mirror neurons; increases motor-evoked potentials.

4. Functional Electrical Stimulation (FES) – 20–50 mA pulses recruit dormant motor units, reducing shoulder subluxation.

5. Neuromuscular Electrical Stimulation cycling – pedals while stimulating quads/gluteals; improves gait speed.

6. Transcranial Magnetic Stimulation (rTMS) – 1 Hz inhibitory over contralesional M1 to unmask ipsilesional cortex.

7. Transcranial Direct Current Stimulation (tDCS) – 2 mA anodal boost on affected hemisphere for 20 min/day.

8. Robot-assisted arm exoskeleton training – precise trajectory guidance, accelerates arm-hand recovery.

9. Body-Weight-Supported Treadmill Training – harness unloads 30 % body weight to practice symmetric gait.

10. Aquatic Therapy – buoyancy allows early standing and reduces spasticity through warmth.

11. Whole-body Vibration Therapy – 30 Hz plate stimulates proprioceptors, reduces ankle clonus.

12. Virtual-Reality Gaming – Kinect®-based reach & balance games heighten motivation and neuroplasticity.

13. Thermal Contrast Therapy – alternating hot/cold packs dampen pain and swelling.

14. Orthotic Bracing & functional splints – positions wrist and thumb to prevent contracture.

15. Low-level Laser Therapy (photobiomodulation) – emerging; may up-regulate mitochondrial cytochrome-c oxidase.

Exercise, mind-body & education

16. Progressive Resistance Training – 2–3 sets, 8–12 reps at 60–80 % 1-RM, twice weekly to rebuild motor units.

17. Aerobic Cycling or Nu-Step® 150 min/week – elevates BDNF, improves VO₂-peak.

18. Static and dynamic stretching – 30-second holds, three reps, prevents contractures.

19. Balance-board & perturbation training – strengthens ankle strategies.

20. Gait-speed interval walks – short bursts at 110 % preferred speed enhance stride symmetry.

21. Yoga (Hatha) – slow poses plus diaphragmatic breathing calm sympathetic tone, cut BP ~5 mm Hg.

22. Tai Chi / Qigong – slow choreographed shifts improve proprioception and postural sway.

23. Pilates core stabilization – bridges and pelvic tilts reduce trunk lean.

24. Mindfulness-Based Stress Reduction – 45-minute guided meditation reduces depression and fatigue.

25. Music Therapy / Rhythmic Auditory Stimulation – metronome-paced stepping entrains cadence.

26. Art Therapy – fine-motor brush strokes stimulate hand dexterity and self-expression.

27. Biofeedback (surface EMG) – visualizes firing patterns; patients learn to dampen spastic co-contraction.

28. Cognitive-Behavioral Therapy for post-stroke fatigue – targets maladaptive beliefs.

29. Patient & Caregiver Goal-Setting Workshops – SMART goals align rehab tasks.

30. Peer-led Self-Management Education – teaches BP, glucose logging, medication adherence.

key drugs

1. Alteplase 0.9 mg/kg IV (max 90 mg) | fibrinolytic | within 4.5 h | bleeding, angio-edema. ncbi.nlm.nih.gov

2. Tenecteplase 0.25 mg/kg IV push | fibrinolytic | alternative, especially with planned thrombectomy | bleeding. ahajournals.org

3. Aspirin 160–325 mg load → 81 mg daily | antiplatelet | start 24 h after alteplase | gastric upset, bleeding.

4. Clopidogrel 300 mg load, then 75 mg/d | P2Y12 blocker | combine with aspirin 21 days in minor stroke | rash, neutropenia.

5. Dual antiplatelet (ASA + Clopidogrel) | combo | NIHSS ≤ 3 small infarct | ↑bleeding versus monotherapy.

6. Atorvastatin 80 mg nightly | high-intensity statin | start day 1 | myalgia, transaminitis.

7. Rosuvastatin 40 mg nightly | statin | statin‐intolerant alternatives | same.

8. Apixaban 5 mg twice daily | DOAC | non-valvular AF after 3–14 days | bruising, GI bleed.

9. Rivaroxaban 20 mg nightly with food | DOAC | non-valvular AF | bleeding.

10. Warfarin INR 2-3 | VKA | valvular AF/mechanical valve | lab checks, drug-food interactions.

11. Lisinopril 10–40 mg/d | ACE inhibitor | secondary prevention BP goal <130/80 | cough, hyper-K⁺.

12. Amlodipine 5–10 mg/d | calcium-channel blocker | alt. BP agent | ankle edema.

13. Hydrochlorothiazide 25 mg/d | thiazide diuretic | add-on for BP | hypo-K⁺, photosensitivity.

14. Empagliflozin 10 mg/d | SGLT2 inhibitor | diabetic stroke survivor | genital infections.

15. Metformin 500–2000 mg/d | biguanide | insulin-sensitizer | lactic acidosis (rare).

16. Fluoxetine 20 mg/d | SSRI | enhances motor recovery in select patients | GI upset, hyponatremia.

17. Citicoline 500–1000 mg BID | neuro-protective nucleotide | improves attentional network | insomnia.

18. Edaravone 60 mg IV daily ×14 d | free-radical scavenger | early neuroprotection (Japan) | renal issues.

19. Piracetam 1.6 g TID | nootropic | adjunct cognitive recovery | nervousness.

20. Nimodipine 60 mg q4h | cerebral vasospasm prophylaxis if subarachnoid hemorrhage complicates | hypotension.

Dietary molecular supplements

1. Vitamin D₃ 1,000–2,000 IU/d – lowers inflammatory cytokines; meta-analysis shows up to 17 % stroke-risk drop. eatingwell.com

2. Omega-3 DHA/EPA 1 g/d – competes with arachidonic acid; forms pro-resolving mediators. en.wikipedia.org

3. Coenzyme Q10 100 mg BID – bolsters mitochondrial ATP; antioxidant.

4. Curcumin 500 mg BID (with piperine) – NF-κB inhibition, reduces post-stroke edema.

5. Resveratrol 150 mg/d – SIRT-1 activation, endothelial nitric-oxide boost.

6. Magnesium citrate 300 mg elemental/d – vasodilator, lowers BP.

7. Potassium (dietary 3.4 g/d) – smooth-muscle hyper-polarization; BP control.

8. Alpha-lipoic acid 600 mg/d – regenerates vitamin C/E, chelates metals.

9. L-Arginine 3 g/d – substrate for nitric-oxide synthase; improves flow-mediated dilation.

10. Methyl-folate+B₆+B₁₂ combo (400 µg/ 25 mg/ 1 mg) – drops homocysteine.

Drugs (bisphosphonates, regenerative, viscosupplement, stem-cell based)

1. Alendronate 70 mg once weekly | bisphosphonate | preserves bone in hemiplegia; watch reflux. pubmed.ncbi.nlm.nih.gov

2. Risedronate 35 mg weekly – similar.

3. Zoledronic acid 5 mg IV yearly – potent anti-resorptive, infusion flu-like syndrome.

4. Cerebrolysin 30 mL IV over 15 min ×10 days | regenerative peptide mixture | may enhance neurogenesis.

5. Granulocyte-colony stimulating factor 250 µg/d SC ×5 – mobilizes endogenous stem cells; investigational.

6. Hyaluronic-acid 20 mg intra-articular weekly ×3 | viscosupplement | eases hemiplegic shoulder arthropathy.

7. Umbilical cord-derived MSC 1 × 10⁶ cells/kg IV – shows best composite neurological recovery. pubmed.ncbi.nlm.nih.gov

8. Bone-marrow mononuclear cells 10⁸ intra-arterial one-time – improves Fugl-Meyer scores.

9. Teriparatide 20 µg SC daily | anabolic bone agent | counters disuse osteoporosis.

10. Autologous peripheral-blood CD34⁺ stem infusion 5 × 10⁷ cells – early-phase trials.

Note: Items 4–10 remain experimental; enroll only in regulated trials.

Surgeries & procedures

1. Mechanical thrombectomy (stent-retriever or aspiration) – within 24 h for LVO; raises odds of mRS 0–2 by 30 %. pubmed.ncbi.nlm.nih.gov

2. Direct aspiration first-pass technique (ADAPT) – minimalist catheter suction.

3. Carotid endarterectomy – ≥70 % ipsilateral stenosis after index stroke.

4. Carotid artery stenting – high-risk surgical candidates.

5. Decompressive hemicraniectomy – malignant edema with midline shift >5 mm saves life in <60 y.o.

6. Extracranial–intracranial (STA-MCA) bypass – rare, for flow-limiting stenosis unamenable to stent.

7. Endoscopic third ventriculostomy / EVD – relieves hydrocephalus.

8. Tendon-transfer surgery (pronator→extensor) – restores hand opening in dense spasticity.

9. Achilles-tendon lengthening – corrects equinus foot preventing brace fit.

10. Implantable cortical neuro-prosthesis trial – brain-computer interfaces for hand grasp.

Prevention strategies

1. Keep systolic BP < 130 mm Hg through lifestyle + meds.

2. Stop smoking—nicotine triples re-stroke risk.

3. Adopt a Mediterranean-style diet rich in olive oil & greens.

4. Exercise 150 min/week brisk walking or cycling.

5. Limit alcohol ≤ 1 drink/day (women) or 2 (men).

6. Tighten diabetes control (target HbA1c < 7 %).

7. Drive LDL-C to < 70 mg/dL with high-intensity statin.

8. Anticoagulate atrial fibrillation promptly.

9. Treat sleep apnea with CPAP to cut nocturnal BP spikes.

10. Schedule annual carotid/vascular check-ups if high-risk.

When should you see a doctor—or call emergency services?

• Immediately (call EMS) if speech suddenly slurs, one side of face droops, or an arm won’t rise—every minute equals ~2 million dying neurons.

• Within 24 h of any new numbness, vision dimming, or brief TIA-like spell.

• Every 3–6 months during the first year for medication review, BP and lipid monitoring, and rehab goal resets.

• Sooner if dizziness, palpitations, calf swelling, or sudden headache appear—possible new embolus or hemorrhagic conversion.

Everyday do’s & don’ts

1. Do practice your physiotherapy home-exercise set daily.
   Don’t over-fatigue a spastic limb—respect rest breaks.

2. Do take all prescribed pills exactly on schedule.
   Don’t stop antiplatelets “just for dental work” without clearance.

3. Do keep hydrated (2–2.5 L fluid/day).
   Don’t binge alcohol; it derails BP control.

4. Do eat potassium-rich fruits & green veggies.
   Don’t load saturated fats or high-salt fast food.

5. Do use an ankle-foot orthosis if recommended.
   Don’t walk barefoot on uneven ground—fall risk.

6. Do practice mindful breathing for stress.
   Don’t ignore new mood changes—tell your clinician.

7. Do sleep 7–8 h nightly; good sleep aids plasticity.
   Don’t rely on late-night caffeine or energy drinks.

8. Do join a stroke-survivor peer group.
   Don’t isolate yourself; social activity spurs recovery.

9. Do monitor home BP weekly.
   Don’t share BP pills with relatives—dosing is individual.

10. Do wear medical ID stating “Stroke / Anticoagulant”.
    Don’t skip INR/renal checks if on warfarin/DOAC.

FAQs

1. How long is the treatment window for clot-busting drugs? Up to 4.5 hours for alteplase; tenecteplase similar; some trials extend with perfusion imaging.

2. Can leg weakness appear later? Yes—edema can spread to internal capsule.

3. Are speech problems permanent? With early rehab, 70 % regain functional language by 6–12 months.

4. Is thrombectomy painful? No; performed under conscious sedation or light GA.

5. What if CT is “normal”? Early CT often is; MRI or CT-perfusion detects tissue-at-risk.

6. Can young people get this stroke? Yes—dissection, PFO, or clotting disorders.

7. Does COVID-19 increase the risk? Emerging data show higher clot burden in severe cases.

8. Will I be on blood thinners forever? Depends on the cause—atrial fibrillation yes; plaque without AF usually antiplatelet only.

9. Is stem-cell therapy approved? Not yet; only in clinical trials.

10. When can I drive again? Typically after physician clearance and neuro-psych testing at ≥3 months.

11. Does spasticity mean recovery is blocked? Not necessarily; targeted therapy and meds can uncouple spasm from strength.

12. Are statins safe if my LDL is normal? Yes—pleiotropic vessel-stabilizing effects.

13. Could bisphosphonates affect the heart? Large studies show little-to-no stroke increase when used correctly. pubmed.ncbi.nlm.nih.gov

14. Is vitamin D really necessary in sunny climates? Deficiency still common; check a blood 25-OH vitamin D first.

15. What’s the prognosis? With rapid reperfusion and structured rehab, 50–60 % achieve independent living (mRS 0-2) at 3 months.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 04, 2025.